Timing and why we’re all VCs
TechCrunch LA
FEBRUARY 20, 2019
From the article: Mithril had its best moment yet last week when a portfolio company, Auris Health, sold to Johnson & Johnson for more than $3 billion — returning at least $500 million to the fund. South California is also seeing declining seed investment. All appears well. Carl Larson Photography via Getty Images. Obsessions.
Let's personalize your content